Intravenous Antibiotic Therapy at Home

  1. H. GRANT STIVER, M.D., F.R.C.P.(C);
  2. GORDON O. TELFORD, M.D., F.R.C.P.(C);
  3. JANA M. MOSSEY, Ph.D.;
  4. DENNIS D. COTE, M.Sc.(Pharm);
  5. ELIZABETH J. VAN MIDDLESWORTH, B.Sc.(Pharm);
  6. SHARON K. TROSKY, R.N.;
  7. NORMA L McKAY, B.N.; and
  8. WILFRED L. MOSSEY, M.S.P.H.
  1. Winnipeg
    , Canada

    Abstract

    During a 12-month period, 23 patients aged 12 to 78 years were treated for 8 to 40 days (mean, 23 days) at home with intravenous (i.v.) antibiotics. Diseases treated included bone and joint infection (14 patients), blastomycosis (two), actinomycosis (two), staphylococcal bacteremia (two), endocarditis (two), and candidal pyelonephritis (one). After initial in-hospital training, patients self-administered their drugs through a heparin-lock i.v. cannula, which was changed regularly by a visiting home care nurse. Antibiotics administered included cloxacillin, penicillin G, cephalosporins, gentamicin, carbenicillin, and amphotericin B. Patient and family acceptance of the program was good, the program was therapeutically effective, and, apart from a decreased prevalence of phlebitis with the heparin lock at home, side effects were no different from those of in-hospital-treated patients. The cost of home therapy was $40 per patient-day compared with an estimated $137 had the patients remained in hospital. Most patients were able to resume normal activities while receiving home i.v. therapy.

    Article and Author Information

    • ▸From the Departments of Medicine, Medical Microbiology, and Social and Preventive Medicine, University of Manitoba, and the Section of Infectious Diseases and Department of Pharmacy, St. Boniface Hospital; Winnipeg, Canada.

    • Grant support: in part by Grant 703-32 from the Manitoba Medical Services Foundation, Inc., and by Grant RF76-3 from the St. Boniface Hospital Research Foundation.

    • ▸Requests for reprints should be addressed to H. Grant Stiver, M.D.; Section of Infectious Diseases, St. Boniface Hospital, 409 Tache Ave.; Winnipeg MB R2H 2A6, Canada.

      • Received February 15, 1978.
      • Accepted July 24, 1978.
    « Previous | Next Article »Table of Contents